BIONEXUS GENE LAB CORP (BGLC:NASDAQ)
$2.19 -0.059304 (-2.6365%)
Analysed BIONEXUS GENE LAB CORP (BGLC:NASDAQ) News Sources
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
11-03-2026
yahoo.com
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
23-02-2026
yahoo.com
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
28-01-2026
yahoo.com
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
03-12-2025
yahoo.com
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
02-12-2025
yahoo.com
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
01-12-2025
yahoo.com
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
12-11-2025
yahoo.com
BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities
10-11-2025
yahoo.com
Top Midday Gainers
30-07-2025
yahoo.com
BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology
30-07-2025
yahoo.com
What is the current price of BIONEXUS GENE LAB CORP (BGLC:NASDAQ)?
The current price of BIONEXUS GENE LAB CORP (BGLC:NASDAQ) is $2.19.
BIONEXUS GENE LAB CORP (BGLC:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIONEXUS GENE LAB CORP (BGLC:NASDAQ) since the previous trading day is $-0.059304.
BIONEXUS GENE LAB CORP (BGLC:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIONEXUS GENE LAB CORP (BGLC:NASDAQ) since the previous trading day is -2.6365%.
What is the most recent average sentiment score for BIONEXUS GENE LAB CORP (BGLC:NASDAQ)?
The most recent average sentiment score for BIONEXUS GENE LAB CORP (BGLC:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for BIONEXUS GENE LAB CORP (BGLC:NASDAQ)?
The most recent sentiment for BIONEXUS GENE LAB CORP (BGLC:NASDAQ) is .
SEC-8K** Filing Available For BIONEXUS GENE LAB CORP (BGLC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.